Lung Cancer Screening. Past, Present and Future.

Clinics in Chest Medicine

Volumn 34, Issue 3, 2013, Pages 365-371

  Finigan, James H ^a,b   Kern, Jeffrey A ^a,b  

^a DEPARTMENT OF MEDICINE   (United States)

^b UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

Author keywords

Chest radiograph; Low dose computed tomography; Lung cancer screening; National Lung Screening Trial

Indexed keywords

CANCER DIAGNOSIS; CANCER INCIDENCE; CANCER MORTALITY; CANCER SCREENING; CANCER STAGING; CANCER SURVIVAL; CLINICAL PROTOCOL; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC ACCURACY; DIAGNOSTIC ERROR; FALSE NEGATIVE RESULT; HIGH RISK PATIENT; HUMAN; INTERMETHOD COMPARISON; LOW ENERGY RADIATION; LOW RISK POPULATION; LUNG CANCER; LUNG FUNCTION TEST; LUNG NODULE; PRACTICE GUIDELINE; PREVALENCE; PRIORITY JOURNAL; RADIATION EXPOSURE; REVIEW; SENSITIVITY AND SPECIFICITY; SPUTUM CYTODIAGNOSIS; THORAX RADIOGRAPHY;

CHEST RADIOGRAPH; LOW-DOSE COMPUTED TOMOGRAPHY; LUNG CANCER SCREENING; NATIONAL LUNG SCREENING TRIAL;

AGED; EARLY DETECTION OF CANCER; FEMALE; HISTORY, 20TH CENTURY; HUMANS; LUNG; LUNG NEOPLASMS; MALE; MIDDLE AGED; RADIOGRAPHY, THORACIC; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84883049288     PISSN: 02725231     EISSN: 15578216     Source Type: Journal    
DOI: 10.1016/j.ccm.2013.03.004     Document Type: Review

References (30)

1. Jemal A., Bray F., Center M.M., et al. Global cancer statistics. CA Cancer J Clin 2011, 61(2):69-90.
2. Siegel R., Naishadham D., Jemal A. Cancer statistics, 2012. CA Cancer J Clin 2012, 62(1):10-29.
3. Centers for Disease Control and Prevention (CDC) Current cigarette smoking prevalence among working adults-United States, 2004-2010. MMWR Morb Mortal Wkly Rep 2011, 60(38):1305-1309.
4. Fontana R.S., Sanderson D.R., Woolner L.B., et al. Lung cancer screening: the Mayo program. JOccup Med 1986, 28(8):746-750.
5. Marcus P.M., Bergstralh E.J., Fagerstrom R.M., et al. Lung cancer mortality in the Mayo Lung Project: impact of extended follow-up. JNatl Cancer Inst 2000, 92(16):1308-1316.
6. Frost J.K., Ball W.C., Levin M.L., et al. Early lung cancer detection: results of the initial (prevalence) radiologic and cytologic screening in the Johns Hopkins study. Am Rev Respir Dis 1984, 130(4):549-554.
7. Kubik A., Polak J. Lung cancer detection. Results of a randomized prospective study in Czechoslovakia. Cancer 1986, 57(12):2427-2437.
8. Oken M.M., Hocking W.G., Kvale P.A., et al. Screening by chest radiograph and lung cancer mortality: the Prostate, Lung, Colorectal, and Ovarian (PLCO) randomized trial. JAMA 2011, 306(17):1865-1873.
9. Mettler F.A., Huda W., Yoshizumi T.T., et al. Effective doses in radiology and diagnostic nuclear medicine: a catalog. Radiology 2008, 248(1):254-263.
10. Kaneko M., Eguchi K., Ohmatsu H., et al. Peripheral lung cancer: screening and detection with low-dose spiral CT versus radiography. Radiology 1996, 201(3):798-802.
11. Sone S., Takashima S., Li F., et al. Mass screening for lung cancer with mobile spiral computed tomography scanner. Lancet 1998, 351(9111):1242-1245.
12. Swensen S.J., Jett J.R., Hartman T.E., et al. CT screening for lung cancer: five-year prospective experience. Radiology 2005, 235(1):259-265.
13. Henschke C.I., McCauley D.I., Yankelevitz D.F., et al. Early lung cancer action project: overall design and findings from baseline screening. Lancet 1999, 354(9173):99-105.
14. Henschke C.I., Yankelevitz D.F., Libby D.M., et al. Survival of patients with stage I lung cancer detected on CT screening. NEngl J Med 2006, 355(17):1763-1771.
15. Infante M., Cavuto S., Lutman F.R., et al. Arandomized study of lung cancer screening with spiral computed tomography: three-year results from the DANTE trial. Am J Respir Crit Care Med 2009, 180(5):445-453.
16. Aberle D.R., Adams A.M., Berg C.D., et al. Reduced lung-cancer mortality with low-dose computed tomographic screening. NEngl J Med 2011, 365(5):395-409.
17. Bach P.B., Mirkin J.N., Oliver T.K., et al. Benefits and harms of CT screening for lung cancer: a systematic review. JAMA 2012, 307(22):2418-2429.
18. Berrington de Gonzalez A., Kim K.P., Berg C.D. Low-dose lung computed tomography screening before age 55: estimates of the mortality reduction required to outweigh the radiation-induced cancer risk. JMed Screen 2008, 15(3):153-158.
19. Travis W.D., Brambilla E., Noguchi M., et al. International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society international multidisciplinary classification of lung adenocarcinoma. JThorac Oncol 2011, 6(2):244-285.
20. Russell P.A., Wainer Z., Wright G.M., et al. Does lung adenocarcinoma subtype predict patient survival? A clinicopathologic study based on the new International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society international multidisciplinary lung adenocarcinoma classification. JThorac Oncol 2011, 6(9):1496-1504.
21. Heuvers M.E., Aerts J.G., Hegmans J.P., et al. History of tuberculosis as an independent prognostic factor forlung cancer survival. Lung Cancer 2012, 76(3):452-456.
22. MacMahon H., Austin J.H., Gamsu G., et al. Guidelines for management of small pulmonary nodules detected on CT scans: a statement from the Fleischner Society. Radiology 2005, 237(2):395-400.
23. Tammemagi C.M., Pinsky P.F., Caporaso N.E., et al. Lung cancer risk prediction: prostate, lung, colorectal, and ovarian cancer screening trial models and validation. JNatl Cancer Inst 2011, 103(13):1058-1068.
24. Cassidy A., Myles J.P., van Tongeren M., et al. The LLP risk model: an individual risk prediction model for lung cancer. Br J Cancer 2008, 98(2):270-276.
25. Spitz M.R., Etzel C.J., Dong Q., et al. An expanded risk prediction model for lung cancer. Cancer Prev Res (Phila) 2008, 1(4):250-254.
26. Bach P.B., Gould M.K. When the average applies tono one: personalized decision making about potential benefits of lung cancer screening. Ann Intern Med 2012, 157(8):571-573.
27. Spira A., Beane J.E., Shah V., et al. Airway epithelial gene expression in the diagnostic evaluation of smokers with suspect lung cancer. Nat Med 2007, 13(3):361-366.
28. Mazzone P.J. Analysis of volatile organic compounds in the exhaled breath for the diagnosis of lung cancer. JThorac Oncol 2008, 3(7):774-780.
29. Ostroff R.M., Bigbee W.L., Franklin W., et al. Unlocking biomarker discovery: large-scale application of aptamer proteomic technology for early detection of lung cancer. PLoS One 2010, 5(12):e15003.
30. Boyle P., Chapman C.J., Holdenrieder S., et al. Clinical validation of an autoantibody test for lung cancer. Ann Oncol 2011, 22(2):383-389.